Steatotic liver disease progression in persons with HIV: weighting for answers

Affiliations

¹ Center for HIV and Hepatogastroenterology, Duesseldorf, Germany.
² The Iowa City Veterans Healthcare System and the University of Iowa, Iowa City, Iowa.
³ Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Editorial

Stefan Mauss et al. AIDS. 2024.

. 2024 Jul 15;38(9):1432-1434.

doi: 10.1097/QAD.0000000000003893. Epub 2024 Jun 27.

¹ Center for HIV and Hepatogastroenterology, Duesseldorf, Germany.
² The Iowa City Veterans Healthcare System and the University of Iowa, Iowa City, Iowa.
³ Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

No abstract available

Comment on

The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV.
Guaraldi G, Milic J, Renzetti S, Motta F, Cinque F, Bischoff J, Desilani A, Conti J, Medioli F, Del Monte M, Kablawi D, Elgretli W, Calza S, Mussini C, Rockstroh JK, Sebastiani G. Guaraldi G, et al. AIDS. 2024 Jul 15;38(9):1323-1332. doi: 10.1097/QAD.0000000000003903. Epub 2024 Apr 18. AIDS. 2024. PMID: 38597416 Free PMC article.

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease . Mayo Clin Proc 1980; 55:434–438.
1. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature . Hepatology 2023; 78:1966–1986.
1. Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. 2019 Global NAFLD prevalence: a systematic review and meta-analysis . Clin Gastroenterol Hepatol 2022; 20:2809–2817. e28.
1. Huh Y, Cho YJ, Nam GE. Recent epidemiology and risk factors of nonalcoholic fatty liver disease . J Obes Metab Syndr 2022; 31:17–27.
1. Bailin SS, Gabriel CL, Wanjalla CN, Koethe JR. Obesity and weight gain in persons with HIV . Curr HIV/AIDS Rep 2020; 17:138–150.